Joon-Il Choi1, Seung Eun Jung2, Woo Kyoung Jeong3, Hyun Cheol Kim4, Chandana Lall5, Yeol Kim6, Kui Son Choi6, Mina Suh7, Boyoung Park6. 1. Department of Radiology, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea. 2. Department of Radiology, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea. sejung@catholic.ac.kr. 3. Department of Radiology, Samsung Medical Center, Sungkyunkwan University, Seoul, Republic of Korea. 4. Department of Radiology, Kyung Hee University Hospital at Gangdong, Seoul, Republic of Korea. 5. Department of Radiological Sciences, University of California, Irvine, USA. 6. Department of Radiological Sciences, University of California, Irvine, USA; National Cancer Control Institute, National Cancer Center, Goyang, Gyeonggi-do, Republic of Korea. 7. National Cancer Control Institute, National Cancer Center, Goyang, Gyeonggi-do, Republic of Korea.
Abstract
AIM: To evaluate the usefulness of on-site education for clinical imaging evaluation using quality assurance (QA) testing of surveillance ultrasonography (US) for hepatocellular carcinoma (HCC). MATERIAL AND METHODS: Thirty-eight medical institutes underwent on-site education in 2012 for QA testing of clinical imaging evaluation of surveillance US for HCC. Failure rates and mean scores of clinical imaging evaluation for surveillance US of the 2011 survey, the 2012 survey after on-site education and the 2013 survey were compared. RESULTS: Failure rates and mean scores of the 2011 survey, the 2012 survey after education and the 2013 survey were 81.6%, 18.4%, 21.1% and 61.7, 82.7 and 74.6, respectively. Pair-wise analyses demonstrated that the failure rate of the 2011 survey was significantly larger compared to that observed in the other surveys. Mean score of the 2013 survey was worse than that of the 2012 survey after on-site education. CONCLUSIONS: On-site education positively impacts the failure rate and scores of clinical imaging evaluation of screening US for HCC. However, the impact may be reduced over time, and repeated, annual education might be necessary to maintain US quality.
AIM: To evaluate the usefulness of on-site education for clinical imaging evaluation using quality assurance (QA) testing of surveillance ultrasonography (US) for hepatocellular carcinoma (HCC). MATERIAL AND METHODS: Thirty-eight medical institutes underwent on-site education in 2012 for QA testing of clinical imaging evaluation of surveillance US for HCC. Failure rates and mean scores of clinical imaging evaluation for surveillance US of the 2011 survey, the 2012 survey after on-site education and the 2013 survey were compared. RESULTS: Failure rates and mean scores of the 2011 survey, the 2012 survey after education and the 2013 survey were 81.6%, 18.4%, 21.1% and 61.7, 82.7 and 74.6, respectively. Pair-wise analyses demonstrated that the failure rate of the 2011 survey was significantly larger compared to that observed in the other surveys. Mean score of the 2013 survey was worse than that of the 2012 survey after on-site education. CONCLUSIONS: On-site education positively impacts the failure rate and scores of clinical imaging evaluation of screening US for HCC. However, the impact may be reduced over time, and repeated, annual education might be necessary to maintain US quality.